Milind Deshpande
2012
In 2012, Milind Deshpande earned a total compensation of $1.5M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,272 |
|---|---|
| Option Awards | $922,084 |
| Salary | $376,100 |
| Other | $7,833 |
| Total | $1,507,289 |
Deshpande received $922.1K in option awards, accounting for 61% of the total pay in 2012.
Deshpande also received $201.3K in non-equity incentive plan, $376.1K in salary and $7.8K in other compensation.
Rankings
In 2012, Milind Deshpande's compensation ranked 4,553rd out of 11,487 executives tracked by ExecPay. In other words, Deshpande earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,553 out of 11,487 | 60th |
Division Manufacturing | 1,580 out of 4,253 | 63rd |
Major group Chemicals And Allied Products | 363 out of 1,203 | 70th |
Industry group Drugs | 227 out of 925 | 76th |
Industry Pharmaceutical Preparations | 176 out of 700 | 75th |
Source: SEC filing on April 17, 2015.
Deshpande's colleagues
We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2012.
2012
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2012
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2012
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2012
Joseph Truitt
Achillion Pharmaceuticals